DKSH Business Unit Healthcare, a Strategic Healthcare Solutions Partner and leading provider of Market Expansion Services for pharmaceutical, over-the-counter (OTC), consumer health and medical device companies, and Kyowa Kirin, a Japan-based Global Specialty Pharmaceutical Company, celebrate the activation of the recently announced partnership with a signing ceremony in Tokyo, Japan. The partnership will be initiated in South Korea, Taiwan, Singapore, Thailand, Malaysia, Hong Kong and Macau, starting on October 1, 2024.

Under this strategic partnership, DKSH will implement an alliance business model that delivers end-to-end healthcare solutions prioritizing healthcare access to patients. The scope of the collaboration includes Kyowa Kirin’s established portfolio for all six markets as well as global brands such as Crysvita and Poteligeo for Hong Kong, Macau, Thailand, Malaysia, and Singapore. The partnership also includes the transition of Kyowa Kirin employees over to DKSH across these markets, ensuring strong process and knowledge continuity throughout the transition.

“Guided by our ‘Story for Vision 2030’, we have defined a plan to transform our Asia-Pacific (APAC) business to maximize patient access to our medicines and for more optimized and sustainable operations. This requires choosing the right partner to support our transformation journey. Recognizing DKSH’s deep expertise in nephrology, robust distribution networks, strong commercial capabilities, and an important commitment to our employees we are confident that DKSH is the right partner,” stated Abdul Mullick, Ph.D., Chief International Business Officer (CIBO), Kyowa Kirin.  

Bijay Singh, Global Head Business Unit Healthcare, Member of the Executive Committee, DKSH, added: “We are truly excited to be the strategic healthcare solution partner of Kyowa Kirin. The teams from both companies have worked closely in the past months to prepare for a seamless business transition. Tremendous work has gone into building the plans for transition of employees, regulatory requirements, supply chain integration, medical affairs, and commercial plans. I am very proud to see that the teams have collaborated with openness and trust to find the best way forward and overcome any challenges that came along the way. At DKSH, we believe that trust is foundational for all successful long-term partnerships. We look forward to a long and fruitful partnership, with a successful kick off starting in October 2024.”  

#DKSH #KyowaKirin #Partnership #Healthcare #Pharmaceutical #OTC #ConsumerHealth #MedicalDevices #AsiaPacific #APAC #SouthKorea #Taiwan #Singapore #Thailand #Malaysia #HongKong #Macau #Collaboration #StrategicPartnership #Business #Industry #Innovation #Leadership #Success #Growth #Development #Future #Trends #IndustryNews #BusinessNews #TechNews

Twitter